65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79718D0396
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65 Solicitation number
Last date to order 95% complete
IDV ceiling
$225,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Pharming Healthcare, Inc. (UEI: PKF3SPXSCHA6) holds a Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs program (FSS-61-IB), awarded on April 1, 2018, by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple-award, non-set-aside Federal Supply Schedule contract establishes a ceiling value of $225,000.00 and remains in effect through March 31, 2027. The contract vehicle enables the ordering of pharmaceutical products, specifically specialty biopharmaceuticals used in the treatment of rare bleeding disorders and related hematology conditions.

Under this Federal Supply Schedule contract, Pharming Healthcare, Inc. delivers two primary biopharmaceutical products: Ruconest (a plasma-derived C1-esterase inhibitor indicated for hereditary angioedema) and Joenja (a hemostasis-related therapeutic). The government has exercised pricing authority through two subsidiary Blanket Purchase Agreements—one awarded December 7, 2018, with a $500,000.00 ceiling (expired December 6, 2023) and a second awarded March 13, 2024, with a $900,000.00 ceiling extending through March 12, 2027, which represents Option Year 2 of the original BPA. These single-award blanket purchase agreements establish pre-priced, indefinite-quantity procurement mechanisms that streamline ordering while ensuring price certainty and supply continuity for the Veterans Integrated Service Network 12's pharmaceutical requirements for these critical specialty medications.

IDV awards

IDV Agency Ceiling Awarded
36E79724A0010 BPA for joenja and ruconest National Acquisition Center (VA) $900,000
36E79719A0009 BPA for ruconest National Acquisition Center (VA) $500,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00028 · Signatory authority $0
Supplemental Agreement for work within scope P00027 · Temporary contract extension $0
Supplemental Agreement for work within scope P00026 · 2026 pricing updates $0
Supplemental Agreement for work within scope P00025 · Temporary contract extension $0
Supplemental Agreement for work within scope P00024 · PL 2025 price updates $0
Other Administrative Action P00023 · Administrative change of point of contacts $0
Supplemental Agreement for work within scope P00022 · Economic price adjustment (EPA) $0
Supplemental Agreement for work within scope P00020 · Temporary contract extension $0
Supplemental Agreement for work within scope P00021 · PL2024 pricing updates $0
Supplemental Agreement for work within scope P00019 · Temporary FCP pricing $0
Supplemental Agreement for work within scope P00018 · Product addition $0
Supplemental Agreement for work within scope P00017 · Tracking customer change $0
Other Administrative Action P00016 · Administrative change to point of contact $0
Supplemental Agreement for work within scope P00014 · Price increase and administrative change $0
Supplemental Agreement for work within scope P00015 · Temporary contract extension $0
Supplemental Agreement for work within scope P00013 · PL2023 pricing updates $0
Other Administrative Action P00012 · Administrative change to sales administration $0
Other Administrative Action P00011 · Administrative change to add new address, updated signature authority form and point of contacts $0
Supplemental Agreement for work within scope P00010 · 2022 public law 102-585 pricing updates $0
Supplemental Agreement for work within scope P00009 · Deletions $0
Supplemental Agreement for work within scope P00008 · 2021 pricing updates $0
Supplemental Agreement for work within scope P00007 · Temporary price reduction $0
Supplemental Agreement for work within scope P00006 · 2020 public law 102-585 updates $0
Other Administrative Action P00005 · Administrative change to add sales POC $0
Supplemental Agreement for work within scope P00004 · NDC change $0
Supplemental Agreement for work within scope P00003 · Temporary price reduction modification $0
Supplemental Agreement for work within scope P00002 · Public law 2019 updates $0
Supplemental Agreement for work within scope P00001 · Administrative point of contact and IFF/sales reporting point of contact modification $0
Original award $0
Show all 29

Quick answers

Who was awarded contract 36F79718D0396?

36F79718D0396 was awarded to Pharming Healthcare, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2018.

How much is contract 36F79718D0396 worth?

36F79718D0396's own ceiling is $225,000.

Who can order from contract 36F79718D0396?

36F79718D0396 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79718D0396 part of a contract vehicle?

Yes. 36F79718D0396 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79718D0396 competed?

The extent of competition for 36F79718D0396 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV